Beyond Locking Doors
How access control data can support operational improvements. Continue reading →Viridian tumbles on positive data for key eye drug prospect
The data did not meet investor expectations, and could bring “fierce investor debate on commercial feasibility,” according to an analyst. Continue reading →Merck strikes deal with antibody discovery startup
In an R&D collaboration worth as much as $838 million, Merck will lean on Infinimmune to discover immune cell-directed antibodies for multiple targets. Continue reading →Biotech IPOs stayed at slow pace, but grew larger in the first quarter of 2026
The six companies that have priced initial public offerings so far banked a median of $287.5 million, a figure far surpassing what’s been observed over a similar timeframe in prior years, according to BioPharma Dive data. Continue reading →
Tax Season Means Phishing Season: How Individuals and Businesses Can Protect Themselves
Tax season-related phishing attacks have gotten more sophisticated as threat actors increasingly leverage generative AI. Continue reading →
Ilana Glazer Fronts Stuart Weitzman’s New ‘Concrete Paradise’ Campaign Chapter for Spring 2026
The global brand ambassador returns after starring in a fall 2025 campaign. Continue reading →
Roblox Doubles Down on Beauty, Launches Makeup for Avatars
The foray is likely to be a profitable one for the Gen Alpha-loved gaming platform, where on-site spending reached $2.2 billion during the fourth quarter of 2025. Continue reading →